Amanda Feilding - The Beckley Foundation: Changing Minds through Psychedelic Research
Release Date: 04/28/2020
In today’s Solidarity Fridays episode, Joe and Kyle discuss recent items in the news and dive into cannabis-assisted psychotherapy after Joe recently helped with his first session. They discuss Compass Pathways' projection that their upcoming stock price could be $14-$16 a share, giving them a possible valuation of as much as $544 million and the problem of having Peter Thiel as one of their leading investors, as it has recently come to surface that he met with white nationalists in 2016 and had good things to say about them. This, in addition to his concerning data-mining company, Palantir...info_outline Ash - CBD, Nootropics, and Micro1p
In this episode, Joe interviews Ash: Netherlands-based psychedelic entrepreneur with his hands in many psychedelic spaces- drug manufacturing company Synergy Trading, nootropics company Cerebra Nootropics, and podcast, Shifty Perspective. Ash talks about his path from trying San Pedro on a farm, to trying DMT and living on the road and in squats for years, to moving to Belgium from the UK, to finding his way into the world of CBD after a friend recommended it for his epileptic girlfriend at the time. When she went from 12 seizures a day to none within a month of starting regular...info_outline Solidarity Fridays - Week 24
In today's Solidarity Fridays episode, Joe and Kyle discuss several recent items in the news that further the advancement of psychedelics, including: Canadian company Havn Lifescience following Compass Pathways' lead and registering with the Canadian Securities Exchange under the symbol HAVN, Amsterdam-based psychedelic retreat company Synthesis announcing that leading Clinical Psychologist Dr. Rosalind Watts has joined their advisory board (which also includes Dr. Robin Carhart-Harris, who joined in November), European psychedelic-assisted psychotherapy company AWAKN Life Sciences Inc....info_outline Wade Davis - Ayahuasca and a New Hope for Colombia
In this episode, Joe interviews Wade Davis: Ph.D., Professor of Anthropology at the University of British Columbia, explorer, ethnobotanist, star of the recent documentary, "El Sendero de la Anaconda," and author of several books, including bestseller The Serpent and the Rainbow, which was optioned for a movie, starring Bill Pullman and released by Universal Pictures in 1988. His new book, Magdalena: River of Dreams: A Story of Colombia, comes out on September 15th. Wade discusses his history with Richard Evans Schultes, the strange phenomenon behind the growth of ayahuasca...info_outline Solidarity Fridays - Week 23
In today's Solidarity Fridays episode, Joe and Kyle discuss recent items in the news. They cover a new LSD microdose trial to study the effects of 5, 10, or 20 µg on acute pain, seeing how long participants could hold their hands in 37.4° F water. Led by researchers from Maastricht University with help from the Beckley Foundation, this is the first study of its kind since Eric Kast first studied the effects of LSD on acute pain in the 1960s, and could help lead to LSD being prescribed for acute pain over the more standard and very addictive and dangerous opioids. This leads towards the topic...info_outline Sara Reed - Ketamine Therapy Through a Culturally Responsible Lens
In this episode, Joe and Kyle interview Sara Reed, MS, LMFT, creator of Mind's Eye Health Solutions, and Director of Psychedelic Services at the Behavioral Wellness Clinic in Connecticut. Reed talks about her path to psychedelics- from graduating with a masters in emerging family therapy and wanting to do research specifically with black Americans, to working with Dr. Monica Williams and eventually MAPS, to being selected as one of the therapists for a phase 3 MDMA-assisted psychotherapy trial (which focused on people of color), to making the transition from practicing with MDMA to ketamine...info_outline Solidarity Fridays - Week 22
In today's Solidarity Fridays episode, Joe and Kyle have, in Joe's words, "a wildly rambling show." They cover topics in the news, including MAPS' recent completion of their Capstone Campaign, a non-profit fundraising effort to fund the final research required to seek FDA approval of MDMA-assisted psychotherapy (through which they raised $30 million from several high-profile names), MindMed's new LSD-MDMA "candy flipping" phase 1 trial set to commence later this year, Representative Earl Blumenauer's (D-OR) fundraising efforts for legal psilocybin and Oregon's ballot initiative becoming a...info_outline Dr. LaMisha Hill - The Fight for Diversity, Inclusion, and Equity
In this episode, Joe interviews Dr. LaMisha Hill, licensed Counseling Psychologist, board member of the Alameda County Psychological Association, and Director of Multicultural Affairs for the Office of Diversity and Outreach at the University of California, San Francisco. Hill talks about how race and gender of underrepresented people come into play in the psychedelic sphere- in studies, professions, and even in people's consideration of psychedelics as a possible healer for them: how most psychology follows the same well-worn, Euro-centric, fairly western, mostly-for-well-off-college-students...info_outline Solidarity Fridays - Week 21
In today's Solidarity Fridays episode, Joe and Kyle sit down and discuss recent items in the news, including the passing of Tav Sparks; author, therapist, co-director of Grof Transpersonal Training, and creator of "Movie Yoga," and scientist Jordi Riba; one of the early pioneers of ayahuasca research and one of the first ever to bring it into the lab. They discuss the ayahuasca episode of the new Netflix docuseries "Unwell," and 2 articles from Marijuana Moment: psychedelic activists in Oakland creating a guideline for plant medicine healing ceremonies and the new initiative to allow for...info_outline Jerry and Julie Brown - Healing Through Mystical Experience
In this episode, Joe interviews Jerry and Julie Brown. Jerry (Ph.D.) is an author and activist, who served as founding professor of anthropology at Florida International University in Miami for 42 years. Julie (M.A.) is an author and integrative psychotherapist, who worked with cancer patients with a focus on guided imagery. Together, they are co-authors of The Psychedelic Gospels: The Secret History of Hallucinogens in Christianity. They talk about their on Psychedelics Today and inspiring studies: Walter Pahnke’s original psilocybin study at Marsh Chapel and Roland Griffiths’...info_outline
In this episode, Joe interviews Amanda Feilding, Founder and Director of The Beckley Foundation. In the show, they cover topics on psychedelic research, policy work, regulation, and the benefits of psychedelics in a time of crisis.
3 Key Points:
- The Beckley Foundation pioneers psychedelic research to drive evidence-based drug policy reform, founded and directed by Amanda Feilding as a UK-based think-tank and NGO.
- There is some interesting research happening around LSD expanding the neuroplasticity of the mind and increasing neurogenesis.
- We are in the midst of a mental health crisis, especially in the West, and psychedelics may be helpful in improving mental health.
The Beckley Foundation
- Amanda says she felt alone for a long time, they were taking a scientific approach, and it was much too serious for the underground
- The Beckley Foundation is doing policy work, medical work, scientific work, etc
- Amanda has a passion for science, but felt a social responsibility to do the policy work
- It's a very destructive work with ‘drugs’, because they are all under the same umbrella, but we psychedelic enthusiasts know, that psychedelics are beneficial and different than other drugs
- Joe mentions he always thought how crazy LSD sentencing is, in some places it is longer than murder charges
- “The ego is really a mirror of the government, and it can be much too restrictive and damaging” - Amanda
- LSD increases cognitive function by expanding the networks of integrative centers in the brain
- Amanda thinks that LSD is better at increasing cognition than mushrooms
- She says they are doing exciting work with LSD and how it expands neuroplasticity of the mind, and how it increases neurogenesis
- She thinks we haven't really even scratched the surface of exploring the benefits of these compounds
- Joe says he is hearing about a lot of athletes using LSD as a performance enhancing drug
- Neuroplasticity is like when the brain becomes hot metal and it can adapt and change
- We have a horrible mental health crisis in the west, 1 in 3 teenage girls are depressed
- Out of all death causes in the US, air pollution is one of the largest
- “Our society needs a paradigm shift” - Amanda
- Amanda says that she doesn't believe that all people need to take psychedelics, but that they can be very beneficial
- Joe says he would love to see regulation everywhere
- The cause of most drug harms are prohibition
- Portugal and Switzerland are great models for boosting public service
- Recognizing the potential benefits helps (starting with medical but not stopping there)
- We are all moving in the right direction
- The spreading of knowledge and education is the right path
- The intuitive gains are the main benefits of these altered states of consciousness
About Amanda Fielding
Amanda Feilding has been called the ‘hidden hand’ behind the renaissance of psychedelic science, and her contribution to global drug policy reform has also been pivotal and widely acknowledged. Amanda was first introduced to LSD in the mid-1960s, at the height of the first wave of scientific research into psychedelics. Impressed by its capacity to initiate mystical states of consciousness and heighten creativity, she quickly recognised its transformative and therapeutic power. Inspired by her experiences, she began studying the mechanisms underlying the effects of psychedelic substances and dedicated herself to exploring ways of harnessing their potential to cure sickness and enhance wellbeing. In 1996, Amanda set up The Foundation to Further Consciousness, changing its name to the Beckley Foundation in 1998.
Support the show
- Leave us a review on iTunes
- Share us with your friends – favorite podcast, etc
- Join our Facebook group - Psychedelics Today group – Find the others and create community.